CGMs are unique in the way consumers have taken it upon themselves to create modifications to medical devices.
The FDA is entering a new era of regulation as whole genome sequencing becomes more accessible to consumers.
Startups and individuals on the cusp of biological breakthroughs.
GV, Google's venture capital arm, is investing in several promising biotechnology startups.
Bioprinting, a technology that emerged from open source communities, has the potential to improve medical science.
Electronic waste is an economic and environmental problem, but citizen scientists can take action by using harvested sensors from discarded electronics.